15 insiders reported 310 Form 4 transactions for Roivant Sciences Ltd. (ROIV) over the past 18 months (most recent 2026-07-02). Recent activity: Torti Frank (President and Vant Chair) Sell 40,310 shares, Fitzgerald Meghan (Director) Buy 10,000 shares, Sukhatme Mayukh (President & CIO) Sell 46,878 shares, Gline Matthew (CEO) Sell 76,171 shares, Fitzgerald Meghan (Director) Sell 10,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Torti Frank | President and Vant Chair | Sell | 40,310 | $1.4M |
| 2026-07-02 | Fitzgerald Meghan | Director | Buy | 10,000 | $88,000 |
| 2026-07-02 | Sukhatme Mayukh | President & CIO | Sell | 46,878 | $1.7M |
| 2026-07-02 | Gline Matthew | CEO | Sell | 76,171 | $2.7M |
| 2026-07-02 | Fitzgerald Meghan | Director | Sell | 10,000 | $349,000 |
| 2026-07-01 | Epperly Melissa B, | Director | Buy | 17,750 | $79,165 |
| 2026-07-01 | Epperly Melissa B, | Director | Sell | 15,002 | $514,869 |
| 2026-07-01 | Epperly Melissa B, | Director | Sell | 2,748 | $95,383 |
| 2026-06-30 | QVT Financial LP | Insider | Sell | 325,000 | $11.1M |
| 2026-06-30 | QVT Financial LP | Insider | Sell | 300,783 | $10.2M |
| 2026-06-30 | Gold Daniel Allen | Director | Sell | 300,783 | $10.2M |
| 2026-06-30 | MANCHESTER KEITH S | Director | Sell | 325,000 | $11.1M |
| 2026-06-30 | MANCHESTER KEITH S | Director | Sell | 300,783 | $10.2M |
| 2026-06-30 | MANCHESTER KEITH S | Director | Sell | 200,000 | $6.9M |
| 2026-06-30 | QVT Financial LP | Insider | Sell | 200,000 | $6.9M |
| 2026-06-30 | Gold Daniel Allen | Director | Sell | 200,000 | $6.9M |
| 2026-06-30 | MANCHESTER KEITH S | Director | Sell | 600,000 | $20.8M |
| 2026-06-30 | QVT Financial LP | Insider | Sell | 600,000 | $20.8M |
| 2026-06-30 | Gold Daniel Allen | Director | Sell | 600,000 | $20.8M |
| 2026-06-30 | MANCHESTER KEITH S | Director | Sell | 12,380 | $436,766 |
| 2026-06-30 | QVT Financial LP | Insider | Sell | 12,380 | $436,766 |
| 2026-06-30 | Gold Daniel Allen | Director | Sell | 12,380 | $436,766 |
| 2026-06-30 | MANCHESTER KEITH S | Director | Sell | 200,000 | $7.1M |
| 2026-06-30 | Gold Daniel Allen | Director | Sell | 325,000 | $11.1M |
| 2026-06-26 | Venker Eric | President & Immunovant CEO | Buy | 200,000 | $770,000 |
Source: SEC Form 4 filings · as of 2026-07-02